In the last trading session, 4.12 million Zimmer Biomet Holdings Inc. (NYSE:ZBH) shares changed hands as the company’s beta touched 1.33. With the company’s per share price at $147.68 changed hands at $6.68 or 4.74% during last session, the market valuation stood at $31.70B. ZBH’s last price was a discount, traded about -22.13% off its 52-week high of $180.36. The share price had its 52-week low at $129.15, which suggests the last value was 12.55% up since then. When we look at Zimmer Biomet Holdings Inc.’s average trading volume, we note the 10-day average is 1.4 million shares, with the 3-month average coming to 1.44 million.
Analysts gave the Zimmer Biomet Holdings Inc. (ZBH) stock a consensus recommendation rating of an Overweight, calculated at a mean rating of 1.90. If we narrow down to specifics, the data shows that 1 out of 30 analysts rate the stock as a Sell, with a further 3 assigning it an Overweight rating. Of the remaining, 5 recommended ZBH as a Hold, 20 felt it is a Buy and 1 rated the stock as Underweight. Zimmer Biomet Holdings Inc.’s EPS for the current quarter is expected to be $1.82.
Zimmer Biomet Holdings Inc. (NYSE:ZBH) trade information
Instantly ZBH was in green as seen at the end of in last trading. With action 0.72%, the performance over the past five days has been green. The jump to weekly highs of 150.10 on Tuesday, 09/14/21 added 4.74% to the stock’s daily price. The company’s shares are showing year-to-date downside of -4.16%, with the 5-day performance at 0.72% in the green. However, in the 30-day time frame, Zimmer Biomet Holdings Inc. (NYSE:ZBH) is 1.09% up. Looking at the short shares, we see there were 2.17 million shares sold at short interest cover period of 1.69 days.
The consensus price target for the stock as assigned by Wall Street analysts is $187.58, meaning bulls need an upside of 21.27% from its current market value. According to analyst projections, ZBH’s forecast low is $134.00 with $210.00 as the target high. To hit the forecast high, the stock’s price needs a -42.2% plunge from its current level, while the stock would need to tank 9.26% for it to hit the projected low.
Zimmer Biomet Holdings Inc. (ZBH) estimates and forecasts
Data shows that the Zimmer Biomet Holdings Inc. share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -7.84% over the past 6 months, a 37.39% in annual growth rate that is considerably higher than the industry average of 15.90%. Moreover, analysts have looked to higher expectations by upgrading its fiscal year 2021 revenue estimates. The rating firms predict current quarter revenue for Zimmer Biomet Holdings Inc. will rise 0.60%, while the growth in revenue is estimated to hit 12.30% for the next quarter. Year-over-year growth is forecast to reach 15.30% up from the last financial year.
Consensus estimates given by 23 financial analysts project the company’s revenue in the current quarter to hit an average of $1.98 billion. 23 analysts are of the opinion that Zimmer Biomet Holdings Inc.’s revenue for the quarter ending Dec 2021 will be $2.25 billion. The company’s revenue for the corresponding quarters a year ago was $1.93 billion and $2.09 billion respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 2.70%. The estimates for the next quarter sales put growth at 8.10%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -23.70%. The 2021 estimates are for Zimmer Biomet Holdings Inc. earnings to decrease by -117.60%, but the outlook for the next 5-year period is at 11.24% per year.
Zimmer Biomet Holdings Inc. is expected to release its next quarterly earnings report between November 04 and November 08. The 0.65% annual yield figure for the share gives it an annual dividend of 0.96. It is important to note, however, that the 0.65% dividend yield ratio should serve as a guide only, as you should also take into consideration many other aspects of a company’s operations and fundamentals before making any investment decision. During the past 5 years, the average dividend yield was 0.76 per year.
Zimmer Biomet Holdings Inc. (NYSE:ZBH)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 0.08% of Zimmer Biomet Holdings Inc. shares while 93.87% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 93.95%. There are 93.87% institutions holding the Zimmer Biomet Holdings Inc. stock share, with Blackrock Inc. the top institutional holder. As of Mar 30, 2021, the company held 10.04% of the shares, roughly 20.93 million ZBH shares worth $3.35 billion.
Vanguard Group, Inc. (The) holds the second largest percentage of outstanding shares, with 7.63% or 15.91 million shares worth $2.55 billion as of Mar 30, 2021.
Among Mutual Funds, the top two as of Mar 30, 2021 were Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund. With 5.86 million shares estimated at $938.4 million under it, the former controlled 2.81% of total outstanding shares. On the other hand, Vanguard 500 Index Fund held about 2.04% of the shares, roughly 4.26 million shares worth around $681.38 million.